India  

Covid-19: Govt says the rate of doubling improves to 7.5 days, Kerala best at 72.2 days | Oneindia

Video Credit: Oneindia - Duration: 02:45s - Published
Covid-19: Govt says the rate of doubling improves to 7.5 days, Kerala best at 72.2 days | Oneindia

Covid-19: Govt says the rate of doubling improves to 7.5 days, Kerala best at 72.2 days | Oneindia

The rate of doubling of Covid-19 cases in India has now improved to 7.5 days India’s Covid-19 doubling rate has improved to 7.5 days from 3.4 days before the lockdown.

After Uttar Pradesh, five more states will send buses to fetch their students stranded in coaching hub Kota in Rajasthan because of the nationwide coronavirus lockdown.

The Rajya Sabha secretariat partially resumed functioning today – Day 27 of the nationwide lockdown -- amid necessary safeguards against spread of corona virus.

And more news #CoronavirusLockdown #COVID19 #CoronavirusOutbreak


You Might Like


Related videos from verified sources

Covid-19 l 'Curfew extended by 2 weeks, 4 hour relaxation daily': Punjab CM [Video]

Covid-19 l 'Curfew extended by 2 weeks, 4 hour relaxation daily': Punjab CM

Punjab CM Amarinder Singh has announced that curfew will be extended in Punjab by 2 more weeks. He added that lockdown will be relaxed for 4 hours between 7 and 11 am every day. This decision comes..

Credit: HT Digital Content     Duration: 01:34Published
Covid news with Vikram Chandra: Which districts will continue curbs after May 3? [Video]

Covid news with Vikram Chandra: Which districts will continue curbs after May 3?

Should the govt extend the lockdown beyond May 3 or go for a more targeted approach?  CMs push for a graded exit with continued restrictions in red zones. About 40% of India has not reported a..

Credit: HT Digital Content     Duration: 08:00Published
Covid-19: Plasma therapy clarification; recovery rate over 23%: Govt briefs [Video]

Covid-19: Plasma therapy clarification; recovery rate over 23%: Govt briefs

The Health Ministry on Tuesday said currently plasma therapy is at experimental stage and there is no evidence yet to support that it can be used as treatment for COVID-19. Addressing a press briefing,..

Credit: HT Digital Content     Duration: 16:17Published